Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Formulation Development Outsourcing Market By Services Type (Pre-Formulation, Formulation Development), By Route of Formulation (Oral, Injectable, Others), By End-user (Pharmaceutical Industries, Research and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031

A31380

Pages: 240

Charts: 53

Tables: 107

Formulation Development Outsourcing Market Research, 2031

The global formulation development outsourcing market size was valued at $22.5 billion in 2021, and is projected to reach $51.9 billion by 2031, growing at a CAGR of 9% from 2022 to 2031. The formulation development outsourcing market demand is growing rapidly owing to increasing number of clinical trials and regulatory requirements. The need for specialized knowledge in formulation development and regulatory compliance can be met through outsourcing, as these service providers have extensive experience and expertise in the field.

[COVIDIMPACTSTATEMENT]

The formulation development outsourcing market size is driven by increasing demand for biopharmaceuticals, advanced drug delivery systems, and complex dosage forms has further fueled the growth of the formulation development outsourcing market. These advanced drug delivery systems require specialized formulation development, which can be met through outsourcing, leading to the growth of the market. The increased demand for cost-effective drug development, the need for specialized expertise, and the growing number of clinical trials and regulatory requirements are the key drivers of the formulation development outsourcing market.

Drug development is a time-consuming, costly, and complex process that is full of uncertainty about whether or not a drug will be successful. Every stage of drug development needs money. Long development timeframes and low success rates result in expensive R&D expenses overall. The most significant challenges restricting market growth are structural changes in the pharmaceutical sector and a lack of funds to complete the medication development process through formulation development.

Chronic diseases and conditions are becoming more common all over the world. Europe's pharmaceutical and biotechnology businesses have boosted their R&D spending in recent years in response to the growing demand for novel drugs. This might be attributed to an aging population, chronic illnesses, and infectious diseases. The creation of anti-cancer pharmaceutical formulations is crucial since formulation includes stability, solubility, and bioavailability throughout drug development.

Global awareness of vaccines is leading to a surge in outsourcing formulation development services. Also, more and more pharma/biopharma companies are planning to partner with Contract Development & Manufacturing Organization (CDMOs), much of this activity is occurring in the early phase of development with the goal of overcoming risk, along with saving time and money as a drug passes through the development pipeline.

The key players profiled in this report include Charles River Laboratories. Syngene International Limited, Catalent, Inc, Piramal Pharma Ltd., Intertek Group plc, Thermo Fisher Scientific, Eurofins Scientific, Laboratory Corporation of America Holdings., Dr. Reddy’s Laboratories Ltd., and EMERGENT.

The global formulation development outsourcing market is segmented on the basis of service type, route of formulation, end user, and region. By service type, the market is segmented into pre-formulation, formulation development. By route of formulation, the market is classified into oral, injectable, and others. By end user, the market is segmented into pharmaceutical industries, research and academic institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The formulation development outsourcing market is segmented into Services Type, Route of Formulation and End-user.

[SERVICESTYPEGRAPH]

By services type, the pre-formulation segment dominated the market in 2021. Pre formulation helps researchers narrow down potential leads by evaluating their physicochemical and biological characteristics. Every stage of clinical trials requires the development of a formulation, and the number of clinical research has greatly expanded over time. The market for outsourcing formulation development is projected to benefit from the increasing number of clinical studies. Such factor is expected to drive the market share in the forecast time period.

[ROUTEOFFORMULATIONGRAPH]

By route of formulation, the injectable segment dominated the global formulation development outsourcing market share in 2021. Injectables, also known as parenteral preparations, are sterile pharmaceuticals that are injected directly into a person's body. Solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection, and implants are examples of parenteral preparations. Long-acting injectable formulations are widely used for contraception, the treatment of immunodeficiencies and psychiatric disorders, as well as for adherence to medication in general. This factor is likely to propel market growth in the anticipated time period.

[ENDUSERGRAPH]

By end-user, the pharmaceutical industries segment dominated the global formulation development outsourcing market share in 2021. Rapidly increasing cases of chronic illness among people and rising demand for potent drugs or vaccine has boosted the pharmaceutical companies to initiate their research and development activities and develop new drugs. Many pharma companies, already have drugs in their pipelines and at different clinical stages. Thus, high demand from pharmaceutical companies for new drug and vaccine development is expected to drive the formulation development outsourcing market in the forecast time period.

[REGIONGRAPH]

By region, North America dominated the global market in 2021 and is projected to remain the fastest-growing segment during the forecast period. The U.S. formulation development market is anticipated to have substantial expansion in the research industry due to the increased prevalence of chronic diseases and high demand for new and effective drugs to treat these diseases. Also, number of clinical trials for drug development in the region is extremely high.

Impact of COVID-19 on the Global Formulation Development Outsourcing Industry

  • The global economy was impacted by the COVID-19, and especially the pharmaceutical industry. The largest economic catastrophe in modern history has also been compounded by the health disaster
  • The COVID-19 pandemic has a huge impact on the formulation development outsourcing business as nations' health systems engaged quickly in research and development to combat the virus Manufacturing companies and research agencies either worked alone or collaborated together to find and develop potential treatment drug for the novel coronavirus infection

Highlights of the Report

  • The report provides an exclusive and comprehensive analysis of the global formulation development outsourcing market trends along with the formulation development outsourcing market forecast
  • The report elucidates the formulation development outsourcing market opportunity along with key drivers and restraints of the market. It is a compilation of detailed information and inputs from industry participants and industry experts across the value chain, as well as quantitative and qualitative assessment by industry analysts
  • Porter’s five forces analysis helps analyse the potential of the buyers & suppliers and the competitive scenario of the market for strategy building
  • The report entailing the formulation development outsourcing market analysis maps the qualitative sway of various industry factors on market segments as well as geographies
  • The data in this report aims on market dynamics, trends, and developments affecting the formulation development outsourcing market growth

  

 Key Market Segments

  • By Services Type
    • Pre-Formulation
    • Formulation Development
  • By Route of Formulation
    • Oral
    • Injectable
    • Others
  • By End-user
    • Pharmaceutical Industries
    • Research and Academic Institutes
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • Piramal Pharma Limited
  •  Intertek Group Plc
  • Catalent Inc
  • syngene international limited
  • Dr Reddy's Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Charles River Laboratories International, Inc.
  • Emergent BioSolutions, Inc.
  • Laboratory Corporation of America Holdings

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

    • 3.4. Market dynamics

      • 3.4.1. Drivers

      • 3.4.2. Restraints

      • 3.4.3. Opportunities

    • 3.5. COVID-19 Impact Analysis on the market

    • 3.6. Key Regulation Analysis

    • 3.7. Market Share Analysis

    • 3.8. Patent Landscape

    • 3.9. Regulatory Guidelines

    • 3.10. Value Chain Analysis

  • CHAPTER 4: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Pre-Formulation

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Formulation Development

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

  • CHAPTER 5: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Oral

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Injectable

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Others

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

  • CHAPTER 6: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Pharmaceutical Industries

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Research and Academic Institutes

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

  • CHAPTER 7: FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Services Type

      • 7.2.3. Market size and forecast, by Route of Formulation

      • 7.2.4. Market size and forecast, by End-user

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Services Type
          • 7.2.5.1.3. Market size and forecast, by Route of Formulation
          • 7.2.5.1.4. Market size and forecast, by End-user
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Services Type
          • 7.2.5.2.3. Market size and forecast, by Route of Formulation
          • 7.2.5.2.4. Market size and forecast, by End-user
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Services Type
          • 7.2.5.3.3. Market size and forecast, by Route of Formulation
          • 7.2.5.3.4. Market size and forecast, by End-user

    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Services Type

      • 7.3.3. Market size and forecast, by Route of Formulation

      • 7.3.4. Market size and forecast, by End-user

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Services Type
          • 7.3.5.1.3. Market size and forecast, by Route of Formulation
          • 7.3.5.1.4. Market size and forecast, by End-user
        • 7.3.5.2. UK
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Services Type
          • 7.3.5.2.3. Market size and forecast, by Route of Formulation
          • 7.3.5.2.4. Market size and forecast, by End-user
        • 7.3.5.3. France
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Services Type
          • 7.3.5.3.3. Market size and forecast, by Route of Formulation
          • 7.3.5.3.4. Market size and forecast, by End-user
        • 7.3.5.4. Spain
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Services Type
          • 7.3.5.4.3. Market size and forecast, by Route of Formulation
          • 7.3.5.4.4. Market size and forecast, by End-user
        • 7.3.5.5. Italy
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Services Type
          • 7.3.5.5.3. Market size and forecast, by Route of Formulation
          • 7.3.5.5.4. Market size and forecast, by End-user
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Services Type
          • 7.3.5.6.3. Market size and forecast, by Route of Formulation
          • 7.3.5.6.4. Market size and forecast, by End-user

    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Services Type

      • 7.4.3. Market size and forecast, by Route of Formulation

      • 7.4.4. Market size and forecast, by End-user

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. China
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Services Type
          • 7.4.5.1.3. Market size and forecast, by Route of Formulation
          • 7.4.5.1.4. Market size and forecast, by End-user
        • 7.4.5.2. Japan
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Services Type
          • 7.4.5.2.3. Market size and forecast, by Route of Formulation
          • 7.4.5.2.4. Market size and forecast, by End-user
        • 7.4.5.3. India
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Services Type
          • 7.4.5.3.3. Market size and forecast, by Route of Formulation
          • 7.4.5.3.4. Market size and forecast, by End-user
        • 7.4.5.4. South Korea
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Services Type
          • 7.4.5.4.3. Market size and forecast, by Route of Formulation
          • 7.4.5.4.4. Market size and forecast, by End-user
        • 7.4.5.5. Australia
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Services Type
          • 7.4.5.5.3. Market size and forecast, by Route of Formulation
          • 7.4.5.5.4. Market size and forecast, by End-user
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Services Type
          • 7.4.5.6.3. Market size and forecast, by Route of Formulation
          • 7.4.5.6.4. Market size and forecast, by End-user

    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Services Type

      • 7.5.3. Market size and forecast, by Route of Formulation

      • 7.5.4. Market size and forecast, by End-user

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Services Type
          • 7.5.5.1.3. Market size and forecast, by Route of Formulation
          • 7.5.5.1.4. Market size and forecast, by End-user
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Services Type
          • 7.5.5.2.3. Market size and forecast, by Route of Formulation
          • 7.5.5.2.4. Market size and forecast, by End-user
        • 7.5.5.3. United Arab Emirates
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Services Type
          • 7.5.5.3.3. Market size and forecast, by Route of Formulation
          • 7.5.5.3.4. Market size and forecast, by End-user
        • 7.5.5.4. South Africa
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Services Type
          • 7.5.5.4.3. Market size and forecast, by Route of Formulation
          • 7.5.5.4.4. Market size and forecast, by End-user
        • 7.5.5.5. Rest of LAMEA
          • 7.5.5.5.1. Key market trends, growth factors and opportunities
          • 7.5.5.5.2. Market size and forecast, by Services Type
          • 7.5.5.5.3. Market size and forecast, by Route of Formulation
          • 7.5.5.5.4. Market size and forecast, by End-user

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Charles River Laboratories International, Inc.

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

    • 9.2. syngene international limited

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

    • 9.3. Catalent Inc

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

    • 9.4. Piramal Pharma Limited

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

    • 9.5.  Intertek Group Plc

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

    • 9.6. Thermo Fisher Scientific Inc.

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

    • 9.7. Eurofins Scientific

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

    • 9.8. Laboratory Corporation of America Holdings

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

    • 9.9. Dr Reddy's Laboratories Ltd.

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

    • 9.10. Emergent BioSolutions, Inc.

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

  • LIST OF TABLES

  • TABLE 01. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 02. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 03. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 04. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 05. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 06. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 07. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 08. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 09. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARMACEUTICAL INDUSTRIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 10. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 11. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 12. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 13. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 14. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 15. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 16. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 17. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 18. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 19. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 20. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 21. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 22. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 23. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 24. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 25. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 26. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 27. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 28. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 29. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 31. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 32. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 33. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 34. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 35. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 36. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 37. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 38. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 39. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 40. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 41. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 42. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 43. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 44. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 45. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 46. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 47. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 48. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 49. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 50. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 51. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 52. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 53. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 54. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 55. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 56. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 57. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 58. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 59. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 60. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 61. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 62. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 63. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 64. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 65. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 66. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 67. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 68. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 69. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 70. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 71. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 72. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 73. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 74. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 75. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 76. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 77. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 78. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 79. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 80. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 81. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 82. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 83. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 84. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 85. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 86. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 87. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 88. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY EXECUTIVES
    TABLE 89. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
    TABLE 90. SYNGENE INTERNATIONAL LIMITED: KEY EXECUTIVES
    TABLE 91. SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT
    TABLE 92. CATALENT INC: KEY EXECUTIVES
    TABLE 93. CATALENT INC: COMPANY SNAPSHOT
    TABLE 94. PIRAMAL PHARMA LIMITED: KEY EXECUTIVES
    TABLE 95. PIRAMAL PHARMA LIMITED: COMPANY SNAPSHOT
    TABLE 96.  INTERTEK GROUP PLC: KEY EXECUTIVES
    TABLE 97.  INTERTEK GROUP PLC: COMPANY SNAPSHOT
    TABLE 98. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
    TABLE 99. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
    TABLE 100. EUROFINS SCIENTIFIC: KEY EXECUTIVES
    TABLE 101. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
    TABLE 102. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
    TABLE 103. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
    TABLE 104. DR REDDY'S LABORATORIES LTD.: KEY EXECUTIVES
    TABLE 105. DR REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT
    TABLE 106. EMERGENT BIOSOLUTIONS, INC.: KEY EXECUTIVES
    TABLE 107. EMERGENT BIOSOLUTIONS, INC.: COMPANY SNAPSHOT

  • LIST OF FIGURES

  • FIGURE 01. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN FORMULATION DEVELOPMENT OUTSOURCING MARKET (2022-2031)
    FIGURE 04. PORTER FIVE-1
    FIGURE 05. PORTER FIVE-2
    FIGURE 06. PORTER FIVE-3
    FIGURE 07. PORTER FIVE-4
    FIGURE 08. PORTER FIVE-5
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALFORMULATION DEVELOPMENT OUTSOURCING MARKET
    FIGURE 10. IMPACT OF KEY REGULATION: FORMULATION DEVELOPMENT OUTSOURCING MARKET
    FIGURE 11. MARKET SHARE ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET
    FIGURE 12. PATENT ANALYSIS BY COMPANY
    FIGURE 13. PATENT ANALYSIS BY COUNTRY
    FIGURE 14. REGULATORY GUIDELINES: FORMULATION DEVELOPMENT OUTSOURCING MARKET
    FIGURE 15. VALUE CHAIN ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET
    FIGURE 16. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY COUNTRY 2021-2031(%)
    FIGURE 19. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY COUNTRY 2021-2031(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY COUNTRY 2021-2031(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 23. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021(%)
    FIGURE 24. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARAMCEUTICAL INDUSTRIES, BY COUNTRY 2021-2031(%)
    FIGURE 25. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY 2021-2031(%)
    FIGURE 26. FORMULATION DEVELOPMENT OUTSOURCING MARKET BY REGION, 2021
    FIGURE 27. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 28. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 29. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 31. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 32. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 33. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 34. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 35. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 36. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 37. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 38. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 39. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 40. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 41. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 43. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 44. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 45. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 46. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)
    FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 51. COMPETITIVE DASHBOARD
    FIGURE 52. COMPETITIVE HEATMAP: FORMULATION DEVELOPMENT OUTSOURCING MARKET
    FIGURE 53. TOP PLAYER POSITIONING, 2021

Purchase Full Report of
Formulation Development Outsourcing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved